Eva Poveda Selected Research

Eva Poveda Research Topics

Disease

19	Infections 01/2022 - 01/2010
11	Hepatitis C 01/2017 - 08/2011
10	HIV Infections (HIV Infection) 10/2017 - 07/2005
7	Acquired Immunodeficiency Syndrome (AIDS) 11/2021 - 06/2008
7	Chronic Hepatitis C 10/2013 - 08/2011
4	COVID-19 01/2022 - 10/2021
4	Fibrosis (Cirrhosis) 11/2021 - 01/2014
3	Neoplasms (Cancer) 05/2022 - 01/2017
3	Viremia 01/2022 - 10/2014
3	Hepatitis B 01/2021 - 04/2013
3	Coinfection 01/2017 - 09/2013
3	Liver Cirrhosis (Hepatic Cirrhosis) 10/2016 - 01/2012
3	Hepatitis D 10/2012 - 01/2011
2	Chronic Hepatitis B 09/2013 - 10/2012
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2022
1	Heart Diseases (Heart Disease) 11/2021
1	Hypertension (High Blood Pressure) 11/2021
1	Diabetes Mellitus 11/2021
1	Chronic Renal Insufficiency 11/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Chronic Disease (Chronic Diseases) 07/2016
1	Shock 10/2014
1	Exanthema (Rash) 01/2014
1	Lung Neoplasms (Lung Cancer) 01/2014
1	Myocardial Infarction 01/2014
1	Abdominal Obesity 01/2014
1	Syphilis 10/2013
1	Superinfection 04/2013
1	Renal Insufficiency (Renal Failure) 10/2008
1	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 01/2003

Drug/Important Bio-Agent (IBA)

11	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2011
11	Antiviral Agents (Antivirals)IBA 01/2017 - 04/2006
7	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 01/2011
4	Pharmaceutical PreparationsIBA 11/2021 - 01/2010
4	DNA (Deoxyribonucleic Acid)IBA 10/2014 - 10/2011
3	Ribavirin (Virazole)FDA LinkGeneric 01/2018 - 08/2011
3	Hepatitis B e AntigensIBA 09/2013 - 01/2011
3	InterferonsIBA 06/2013 - 01/2012
3	Maraviroc FDA Link 12/2011 - 01/2010
2	Immunoglobulin G (IgG)IBA 01/2022 - 10/2021
2	AntibodiesIBA 10/2021 - 04/2013
2	Viral RNAIBA 01/2018 - 10/2013
2	Proteins (Proteins, Gene)FDA Link 10/2017 - 08/2014
2	Tenofovir (Viread)FDA Link 09/2013 - 06/2008
1	VaccinesIBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	PerforinIBA 01/2022
1	RacivirIBA 11/2021
1	Reverse Transcriptase InhibitorsIBA 11/2021
1	NucleosidesIBA 11/2021
1	NucleotidesIBA 11/2021
1	CytokinesIBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	Interleukin-8 (Interleukin 8)IBA 10/2021
1	Immunoglobulin M (IgM)IBA 10/2021
1	Immunoglobulin A (IgA)IBA 10/2021
1	Interferon-alpha (Interferon Alfa)IBA 01/2021
1	N-acetoacetyl-N-deacetylcolchicineIBA 01/2017
1	Mitochondrial DNA (mtDNA)IBA 10/2016
1	Monoclonal AntibodiesIBA 07/2016
1	Histone MethyltransferasesIBA 10/2014
1	Histone Deacetylase InhibitorsIBA 10/2014
1	MethyltransferasesIBA 10/2014
1	Protein Kinase CIBA 10/2014
1	Peptide Hydrolases (Proteases)FDA Link 08/2014
1	HDL CholesterolIBA 01/2014
1	Transaminases (Aminotransferases)IBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	Triglycerides (Triacylglycerol)IBA 01/2014
1	ReaginsIBA 10/2013
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2013
1	Inosine TriphosphataseIBA 03/2012
1	LDL CholesterolIBA 03/2012
1	InterleukinsIBA 03/2012
1	alisporivirIBA 08/2011
1	Lamivudine (Epivir)FDA Link 01/2011
1	tipranavir FDA Link 07/2010
1	Darunavir (Prezista)FDA Link 07/2010
1	efavirenz (Sustiva)FDA Link 01/2010
1	etravirine (TMC-125)FDA Link 01/2010
1	Nevirapine (Viramune)FDA Link 01/2010
1	Cytochrome P-450 CYP3A InhibitorsIBA 10/2008
1	Enfuvirtide (Fuzeon)FDA Link 07/2005

Therapy/Procedure

15	Therapeutics 04/2018 - 01/2011
3	Art Therapy 05/2022 - 01/2017
2	Duration of Therapy 01/2018 - 06/2013
2	Highly Active Antiretroviral Therapy (HAART) 01/2017 - 07/2016
1	Length of Stay 01/2017
1	MVC regimen 01/2014
1	Transplantation 01/2003